$37.05
+0.48 (+1.31%)
Open$37.10
Previous Close$36.57
Day High$37.99
Day Low$36.78
52W High$37.32
52W Low$9.85
Volume—
Avg Volume315.8K
Market Cap1.63B
P/E Ratio—
EPS$-0.82
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+21.3% upside
Current
$37.05
$37.05
Target
$44.96
$44.96
$33.78
$44.96 avg
$58.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 48.22M | 203.59M | 209.55M |
| Net Income | -51,298,964 | 62.98M | 65.23M |
| Profit Margin | -106.4% | 30.9% | 31.1% |
| EBITDA | -69,994,938 | 113.38M | 119.42M |
| Free Cash Flow | — | 53.53M | 45.52M |
| Rev Growth | — | +1.5% | +13.6% |
| Debt/Equity | — | 0.24 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |